SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMCM.L Regulatory News (MCM)

  • There is currently no data for MCM

Appendix 5B

31 Jan 2017 07:00

RNS Number : 5091V
Coal of Africa Limited
31 January 2017
Β 

+Rule 5.5

Appendix 5B

Mining exploration entity and oil and gas exploration entity quarterly report

Introduced 01/07/96 Origin Appendix 8 Amended 01/07/97, 01/07/98, 30/09/01, 01/06/10, 17/12/10, 01/05/13, 01/09/16

Β 

Name of entity

Coal of Africa Limited

ABN

Β 

Quarter ended ("current quarter")

98 008 905 388

Β 

31 December 2016

Β 

Consolidated statement of cash flows

Current quarter $USD'000

Year to date (6 months)$USD'000

Β 

1.

Cash flows from operating activities

191

191

Β 

1.1

Receipts from customers

Β 

1.2

Payments for

-

-

Β 

Β 

(a) exploration & evaluation

Β 

Β 

(b) development

-

-

Β 

Β 

(c) production

-

-

Β 

Β 

(d) staff costs

(666)

(1,745)

Β 

Β 

(e) administration and corporate costs

(1,974)

(4,911)

Β 

1.3

Dividends received (see noteΒ 3)

-

-

Β 

1.4

Interest received

28

79

Β 

1.5

Interest and other costs of finance paid

-

-

Β 

1.6

Income taxes paid

-

-

Β 

1.7

Research and development refunds

-

-

Β 

1.8

Other (provide details if material)

-

-

Β 

1.9

Net cash from / (used in) operating activities

(2,421)

(6,386)

Β 

Β 

Β 

Β 

Β 

2.

Cash flows from investing activities

-

-

Β 

2.1

Payments to acquire:

Β 

Β 

(a) property, plant and equipment

Β 

Β 

(b) tenements (see itemΒ 10)

-

-

Β 

Β 

(c) investments

(681)

(1,270)

Β 

Β 

(d) other non-current assets

-

-

Β 

2.2

Proceeds from the disposal of:

-

-

Β 

Β 

(a) property, plant and equipment

Β 

Β 

(b) tenements (see itemΒ 10)

-

-

Β 

Β 

(c) investments

-

-

Β 

Β 

(d) other non-current assets

1,101

1,101

Β 

2.3

Cash flows from loans to other entities

116

356

Β 

2.4

Dividends received (see noteΒ 3)

-

-

Β 

2.5

Other (provide details if material)

-

-

Β 

2.6

Net cash from / (used in) investing activities

536

187

Β 

Β 

Β 

Β 

Β 

3.

Cash flows from financing activities

-

-

Β 

3.1

Proceeds from issues of shares

Β 

3.2

Proceeds from issue of convertible notes

-

-

Β 

3.3

Proceeds from exercise of share options

-

-

Β 

3.4

Transaction costs related to issues of shares, convertible notes or options

-

-

Β 

3.5

Proceeds from borrowings

-

-

Β 

3.6

Repayment of borrowings

(2,218)

(6,532)

Β 

3.7

Transaction costs related to loans and borrowings

-

-

Β 

3.8

Dividends paid

-

-

Β 

3.9

Other (provide details if material)

-

-

Β 

3.10

Net cash from / (used in) financing activities

(2,218)

(6,532)

Β 

Β 

Β 

Β 

Β 

4.

Net increase / (decrease) in cash and cash equivalents for the period

11,905

20,004

Β 

4.1

Cash and cash equivalents at beginning of period

Β 

4.2

Net cash from / (used in) operating activities (itemΒ 1.9 above)

(2,421)

(6,386)

Β 

4.3

Net cash from / (used in) investing activities (itemΒ 2.6 above)

536

187

Β 

4.4

Net cash from / (used in) financing activities (itemΒ 3.10 above)

(2,218)

(6,532)

Β 

4.5

Effect of movement in exchange rates on cash held

(441)

88

Β 

4.6

Cash and cash equivalents at end of period

7,361

7,361

Β 

Β 

5.

Reconciliation of cash and cash equivalentsat the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts

Current quarter$USD'000

Previous quarter$USD'000

5.1

Bank balances

7,091

11,633

5.2

Call deposits

270

272

5.3

Bank overdrafts

5.4

Other (provide details)

5.5

Cash and cash equivalents at end of quarter (should equal itemΒ 4.6 above)

7,361

11,905

Β 

6.

Payments to directors of the entity and their associates

Current quarter$USD'000

6.1

Aggregate amount of payments to these parties included in itemΒ 1.2

214

6.2

Aggregate amount of cash flow from loans to these parties included in itemΒ 2.3

Β 

6.3

Include below any explanation necessary to understand the transactions included in itemsΒ 6.1 and 6.2

Salary payments for the quarter made to Non-Executive and Executive directors.

Β 

Β 

Β 

7.

Payments to related entities of the entity and their associates

Current quarter$USD'000

7.1

Aggregate amount of payments to these parties included in itemΒ 1.2

Β 

7.2

Aggregate amount of cash flow from loans to these parties included in itemΒ 2.3

Β 

7.3

Include below any explanation necessary to understand the transactions included in itemsΒ 7.1 and 7.2

Β 

Β 

Β 

Β 

8.

Financing facilities availableAdd notes as necessary for an understanding of the position

Total facility amount at quarter end$USD'000

Amount drawn at quarter end$USD'000

8.1

Loan facilities

10,000

10,000

8.2

Credit standby arrangements

8.3

Other (please specify)

8.4

Include below a description of each facility above, including the lender, interest rate and whether it is secured or unsecured. If any additional facilities have been entered into or are proposed to be entered into after quarter end, include details of those facilities as well.

YBI Loan facility of USD10,000. The loan bears no interest and has a potential conversion to equity post 31 December 2016.

Β 

Β 

Β 

9.

Estimated cash outflows for next quarter

$USD'000

9.1

Exploration and evaluation

9.2

Development

(574)

9.3

Production

9.4

Staff costs

(1,089)

9.5

Administration and corporate costs

9.6

Other (Rio Tinto repayment included in this balance)

(3,421)

9.7

Total estimated cash outflows

(5,083)

Β 

10.

Changes in tenements(items 2.1(b) and 2.2(b) above)

Tenement reference and location

Nature of interest

Interest at beginning of quarter

Interest at end of quarter

10.1

Interests in mining tenements and petroleum tenements lapsed, relinquished or reduced

Β 

Β 

Β 

Β 

10.2

Interests in mining tenements and petroleum tenements acquired or increased

Β 

Β 

Β 

Β 

Β 

Compliance statement

1 This statement has been prepared in accordance with accounting standards and policies which comply with Listing RuleΒ 19.11A.

2 This statement gives a true and fair view of the matters disclosed.

Β 

Sign here: ............................................................ Date: .............................................

(Director/Company secretary)

Β 

Print name: .........................................................

Β 

Notes

1. The quarterly report provides a basis for informing the market how the entity's activities have been financed for the past quarter and the effect on its cash position. An entity that wishes to disclose additional information is encouraged to do so, in a note or notes included in or attached to this report.

2. If this quarterly report has been prepared in accordance with Australian Accounting Standards, the definitions in, and provisions of, AASB 6: Exploration for and Evaluation of Mineral Resources and AASB 107: Statement of Cash Flows apply to this report. If this quarterly report has been prepared in accordance with other accounting standards agreed by ASX pursuant to Listing Rule 19.11A, the corresponding equivalent standards apply to this report.

3. Dividends received may be classified either as cash flows from operating activities or cash flows from investing activities, depending on the accounting policy of the entity.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCEAKFEDLSXEFF
Date   Source Headline
24th Jan 20249:30 amRNSNon-Binding and Indicative Proposal Update
22nd Dec 20238:32 amRNSNon-Binding and Indicative Proposal Update
22nd Dec 20237:30 amRNSOperations & Trading Update
18th Dec 20233:30 pmRNSDirector/PDMR Shareholding
18th Dec 20233:02 pmRNSREVISED NON-BINDING AND INDICATIVE PROPOSAL
30th Nov 20232:31 pmRNSResult of Annual General Meeting
27th Nov 20233:03 pmRNSAnnual General Meeting Details
8th Nov 20237:15 amRNSIssue of Equity
2nd Nov 20231:15 pmRNSReceipt of Notice of Intention to Make a Takeover
31st Oct 20232:30 pmRNSDespatch of Annual Report and Notice of AGM
31st Oct 20239:25 amRNSActivities Report for the Quarter Ended 30 Sep 23
31st Oct 20239:25 amRNSAppendix 5B
27th Oct 202310:30 amRNSIssue of Equity
5th Oct 202310:30 amRNSAnnual General Meeting Details
21st Sep 202312:13 pmRNSResults for the Full Year Ended 30 June 2023
15th Sep 202310:10 amRNSChange of Australian Share Registry Address
31st Jul 20239:35 amRNSAppendix 5B
31st Jul 20239:33 amRNSACTIVITIES REPORT FOR QUARTER ENDED 30 JUNE 2023
25th Jul 20237:45 amRNSIDC Extension Announcement
30th Jun 202312:15 pmRNSTrading Update
28th Apr 20239:35 amRNSAppendix 5B
28th Apr 20239:30 amRNSActivities Report for the Quarter Ended 31 Mar 23
27th Apr 20239:00 amRNSHolding(s) in Company
26th Apr 202311:20 amRNSMakhado Project Update
31st Mar 20238:02 amRNSIssue of Shares Under the Performance Rights Plan
16th Mar 20237:00 amRNSChange of JSE Sponsor
15th Mar 20237:40 amRNSInterim Financial Report
15th Mar 20237:40 amRNSHalf-year Results
10th Mar 20231:00 pmRNSDirector Appointments & Resignation
22nd Feb 20232:05 pmRNSSecond Price Monitoring Extn
22nd Feb 20232:00 pmRNSPrice Monitoring Extension
31st Jan 20237:31 amRNSAppendix 5B
31st Jan 20237:30 amRNSActivities Report for the Quarter Ended 31 Dec 22
19th Jan 20232:15 pmRNSGrant of Options & Performance Rights to Directors
23rd Dec 20228:37 amRNSOutsourcing of the Vele Aluwani Colliery
20th Dec 20223:00 pmRNSExtension of Coal Sales & Marketing Agreement
1st Dec 20229:00 amRNSIDC Loan Update
30th Nov 20224:32 pmRNSResult of AGM
11th Nov 20226:20 pmRNSDirectors' Dealings
4th Nov 20222:06 pmRNSSecond Price Monitoring Extn
4th Nov 20222:00 pmRNSPrice Monitoring Extension
4th Nov 202210:00 amRNSFully Underwritten Rights Issue Offer Closes
31st Oct 20229:31 amRNSAppendix 5B
31st Oct 20229:30 amRNSActivities Report for the Quarter Ended 30 Sep 22
31st Oct 20227:00 amRNSDespatch of Annual Report and Notice of AGM
7th Oct 202211:07 amRNSAnnual General Meeting Details
30th Sep 20229:45 amRNSResults for the Full Year Ended 30 June 2022
28th Sep 20222:05 pmRNSSecond Price Monitoring Extn
28th Sep 20222:00 pmRNSPrice Monitoring Extension
27th Sep 20227:00 amRNSFully Underwritten A$40M Rights Issue

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.